One of our goals at HITLAB is to make healthcare simpler and more intuitive. We created the international HITLAB World Cup competition to improve healthcare delivery, access, and outcomes. This event identifies and supports innovators who help patients around the world manage, understand, and take part in their health. Past winners have gone on to raise over $50 million in follow-on funding and launch commercially viable products that are transforming lives.
This year’s event, the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk is centered on Type 2 diabetes, a condition affecting over 422 million people worldwide. Our finalists created innovative solutions using voice-activated technology to make it easier for diabetics to manage their care. At the HITLAB World Cup, the five demos will be judged on their impact, innovation, sustainability, and feasibility, with a grand prize of $50,000 going to the winner and $75,000 in total prizes.